Lv73
4414 积分 2021-02-18 加入
Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis
1小时前
待确认
Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy
2小时前
待确认
Structure-Based Drug Design for G Protein-Coupled Receptors
1天前
已完结
Targeting ion channels with ultra-large library screening for hit discovery
6天前
已完结
Ion channel drug discovery: challenges and future directions
6天前
已完结
TRPV4 antagonists: a patent review (2015–2020)
10天前
已完结
Targeting cancer with molecular glues
14天前
已完结
Chemical remodeling of a cellular chaperone to target the active state of mutant KRAS
14天前
已完结
The Identification of GPR52 Agonist HTL0041178, a Potential Therapy for Schizophrenia and Related Psychiatric Disorders
19天前
已完结
Structure-based design of a novel third-generation antipsychotic drug lead with potential antidepressant properties
21天前
已完结
皖公网安备34019202002308
